Among 29 distinct biomarkers, an ML-based approach identified three top-scoring biomarkers—NT-proBNP, Apo A-I and KIM-1—for the prediction of 1-year MACE in patients with symptoms indicative of MI. This evidence concerns the gene NPPB and myocardial infarction.